MENU
+Compare
THRD
Stock ticker: NASDAQ
AS OF
Apr 3, 04:59 PM (EDT)
Price
$3.58
Change
+$0.03 (+0.85%)
Capitalization
161.02M

THRD Third Harmonic Bio Forecast, Technical & Fundamental Analysis

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases... Show more

THRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for THRD with price predictions
Apr 02, 2025

THRD's RSI Indicator ascends from oversold territory

The RSI Oscillator for THRD moved out of oversold territory on March 04, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 5 similar instances when the indicator left oversold territory. In of the 5 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 02, 2025. You may want to consider a long position or call options on THRD as a result. In of 54 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where THRD advanced for three days, in of 119 cases, the price rose further within the following month. The odds of a continued upward trend are .

THRD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 25 cases where THRD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where THRD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.565) is normal, around the industry mean (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.036).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. THRD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. THRD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
THRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

THRD is expected to report earnings to fall 8.62% to -26 cents per share on May 08

Third Harmonic Bio THRD Stock Earnings Reports
Q1'25
Est.
$-0.26
Q4'24
Beat
by $0.06
Q3'24
Missed
by $0.03
Q2'24
Missed
by $0.01
Q1'24
Beat
by $0.11
The last earnings report on March 27 showed earnings per share of -28 cents, beating the estimate of -35 cents. With 375.15K shares outstanding, the current market capitalization sits at 161.02M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1700 Montgomery Street
Phone
+1 209 727-2457
Employees
30
Web
https://www.thirdharmonicbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VALIX12.190.08
+0.66%
Value Line Capital Appreciation Investor
RYWCX36.21N/A
N/A
Rydex S&P SmallCap 600 Pure Growth C
WMKSX14.40N/A
N/A
WesMark Small Company Fund
BIFRX19.37N/A
N/A
BlackRock International R
JNEMX20.38N/A
N/A
JPMorgan International Equity R6

THRD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, THRD has been loosely correlated with INZY. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if THRD jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THRD
1D Price
Change %
THRD100%
+5.65%
INZY - THRD
46%
Loosely correlated
+6.48%
NVAX - THRD
42%
Loosely correlated
-0.33%
APGE - THRD
40%
Loosely correlated
+6.23%
ACLX - THRD
39%
Loosely correlated
+10.76%
PRME - THRD
37%
Loosely correlated
+0.28%
More